Naltrexone in addicted physicians and business executives.
Naltrexone was administered to 114 opiate-dependent business executives and 15 opiate-dependent physicians as part of a comprehensive outpatient aftercare program following inpatient detoxification using clonidine. Over 80% of patients successfully completed at least six months of treatment without relapse or re-addiction and were still drug-free at 12-18 months follow-up. Patients who completed at least six months of treatment were more likely to be opiate free at follow-up than patients who had dropped out at an earlier point in the program. This study demonstrates that naltrexone can be an extremely useful and appropriate treatment for highly motivated middle/upper class addicts when administered within the context of an intensive high-expectation program.
D003000:Clonidine / Q000627:therapeutic use; D003132:Commerce; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D010820:Physicians; D012959:Socioeconomic Factors; D013997:Time Factors
D009271:Naltrexone; D003000:Clonidine